International Stem Cell CORP
ISCO· OTC
Released Aug 7, 2014, after the close
10-Q filed Aug 8, 2014, 39 days after period end · 0001564590-14-003361
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $1.59M | $1.46M | $1.06M | $1.11M |
| Net Income | -$4.41M | -$2.20M | -$2.48M | -$2.39M |
| EPS Diluted | -$3.88 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.02 |
| -$0.03 |
| -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.